Evaluation of LI-RADS 3 and 4 Lesions
Gastroenterology
.
2024 Nov 29:S0016-5085(24)05649-X.
doi: 10.1053/j.gastro.2024.10.028.
Online ahead of print.
Authors
Amit G Singal
1
,
Bachir Taouli
2
,
Purva Gopal
3
,
Fasiha Kanwal
4
,
Neehar D Parikh
5
Affiliations
1
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas. Electronic address: amit.singal@utsouthwestern.edu.
2
Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York.
3
Department of Pathology, UT Southwestern Medical Center, Dallas, Texas.
4
Department of Medicine, Baylor College of Medicine, Houston, Texas.
5
Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
PMID:
39622280
DOI:
10.1053/j.gastro.2024.10.028
No abstract available
Keywords:
Hepatocellular Carcinoma; LI-RADS; Liver Nodules; Surveillance.